The tetraspanin CD53 modulates responses from activating NK cell receptors, promoting LFA-1 activation and dampening NK cell effector functions

PLoS One. 2014 May 15;9(5):e97844. doi: 10.1371/journal.pone.0097844. eCollection 2014.

Abstract

NK cells express several tetraspanin proteins, which differentially modulate NK cell activities. The tetraspanin CD53 is expressed by all resting NK cells and was previously shown to decrease NK cell cytotoxicity upon ligation. Here, we show that CD53 ligation reduced degranulation of rat NK cells in response to tumour target cells, evoked redirected inhibition of killing of Fc-bearing targets, and reduced the IFN-γ response induced by plate-bound antibodies towards several activating NK cell receptors (Ly49s3, NKR-P1A, and NKp46). CD53 induced activation of the β2 integrin LFA-1, which was further enhanced upon co-stimulation with activating NK cell receptors. Concordant with a role for CD53 in increasing NK cell adhesiveness, CD53 ligation induced a strong homotypic adhesion between NK cells. Further, the proliferative capacity of NK cells to a suboptimal dose of IL-2 was enhanced by CD53 ligation. Taken together, these data suggest that CD53 may shift NK cell responses from effector functions towards a proliferation phase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion
  • Cell Degranulation
  • Cell Line
  • Cell Proliferation
  • Interferon-gamma / biosynthesis
  • Interleukin-2 / physiology
  • Killer Cells, Natural / metabolism*
  • Lymphocyte Function-Associated Antigen-1 / metabolism*
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Rats
  • Receptors, Natural Killer Cell / metabolism*
  • Tetraspanin 25 / physiology*

Substances

  • Cd53 protein, rat
  • Interleukin-2
  • Lymphocyte Function-Associated Antigen-1
  • Receptors, Natural Killer Cell
  • Tetraspanin 25
  • Interferon-gamma

Grants and funding

This work was supported by the South-Eastern Norway Regional Health Authority grant number 2008100 BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.